<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39060438</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>148</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>25</Day></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains.</ArticleTitle><Pagination><StartPage>11</StartPage><MedlinePgn>11</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-024-02770-6</ELocationID><Abstract><AbstractText>The underlying pathogenesis of neurological sequelae in post-COVID-19 patients remains unclear. Here, we used multidimensional spatial immune phenotyping and machine learning methods on brains from initial COVID-19 survivors to identify the biological correlate associated with previous SARS-CoV-2 challenge. Compared to healthy controls, individuals with post-COVID-19 revealed a high percentage of TMEM119<sup>+</sup>P2RY12<sup>+</sup>CD68<sup>+</sup>Iba1<sup>+</sup>HLA-DR<sup>+</sup>CD11c<sup>+</sup>SCAMP2<sup>+</sup> microglia assembled in prototypical cellular nodules. In contrast to acute SARS-CoV-2 cases, the frequency of CD8<sup>+</sup> parenchymal T cells was reduced, suggesting an immune shift toward innate immune activation that may contribute to neurological alterations in post-COVID-19 patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schwabenland</LastName><ForeName>Marius</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2205-5427</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasavci</LastName><ForeName>Dilara</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frase</LastName><ForeName>Sibylle</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deigendesch</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6036-3327</Identifier><AffiliationInfo><Affiliation>Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buescher</LastName><ForeName>Joerg M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Immunobiology and Epigenetics, 79108, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mertz</LastName><ForeName>Kirsten D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Institute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ondruschka</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altmeppen</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matschke</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glatzel</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thimme</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beck</LastName><ForeName>Juergen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosp</LastName><ForeName>Jonas A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blank</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bengsch</LastName><ForeName>Bertram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinz</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0349-1955</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany. marco.prinz@uniklinik-freiburg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany. marco.prinz@uniklinik-freiburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002921" MajorTopicYN="N">Cicatrix</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Imaging mass cytometry</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Neuro-long-COVID-19</Keyword><Keyword MajorTopicYN="N">PACS</Keyword><Keyword MajorTopicYN="N">PCC</Keyword><Keyword MajorTopicYN="N">Post-COVID condition</Keyword><Keyword MajorTopicYN="N">Post-acute COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>28</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39060438</ArticleId><ArticleId IdType="pmc">PMC11281987</ArticleId><ArticleId IdType="doi">10.1007/s00401-024-02770-6</ArticleId><ArticleId IdType="pii">10.1007/s00401-024-02770-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boettler T, Csernalabics B, Salie H, Luxenburger H, Wischer L, Salimi Alizei E et al (2022) SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis. J Hepatol 77:653&#x2013;659. 10.1016/j.jhep.2022.03.040 10.1016/j.jhep.2022.03.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2022.03.040</ArticleId><ArticleId IdType="pmc">PMC9021033</ArticleId><ArticleId IdType="pubmed">35461912</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z (2023) Postacute sequelae of COVID-19 at 2 years. Nat Med 29:2347&#x2013;2357. 10.1038/s41591-023-02521-2 10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C, Bruningk SC, Hoch T, Fan B, Muzio G, Thompson RC et al (2024) Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science 383:eadg7942. 10.1126/science.adg7942 10.1126/science.adg7942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. 10.1016/j.eclinm.2021.101019 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604:697&#x2013;707. 10.1038/s41586-022-04569-5 10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilertz D, Mitterer M, Buescher JM (2022) automRm: an R package for fully automatic LC-QQQ-MS data preprocessing powered by machine learning. Anal Chem 94:6163&#x2013;6171. 10.1021/acs.analchem.1c05224 10.1021/acs.analchem.1c05224</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.1c05224</ArticleId><ArticleId IdType="pmc">PMC9047440</ArticleId><ArticleId IdType="pubmed">35412809</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D, Dokalis N, Mezo C, Castoldi A, Mossad O, Staszewski O et al (2021) Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab 33(2260&#x2013;2276):e2267. 10.1016/j.cmet.2021.10.01010.1016/j.cmet.2021.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.10.010</ArticleId><ArticleId IdType="pubmed">34731656</ArticleId></ArticleIdList></Reference><Reference><Citation>Floro S, Carandini T, Pietroboni AM, De Riz MA, Scarpini E, Galimberti D (2022) Role of chitinase 3-like 1 as a biomarker in multiple sclerosis: a systematic review and meta-analysis. Neurol Neuroimmunol Neuroinflamm. 10.1212/NXI.0000000000001164 10.1212/NXI.0000000000001164</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001164</ArticleId><ArticleId IdType="pmc">PMC9128043</ArticleId><ArticleId IdType="pubmed">35534236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M et al (2021) Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144:1263&#x2013;1276. 10.1093/brain/awab009 10.1093/brain/awab009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR et al (2023) Distinguishing features of long COVID identified through immune profiling. Nature 623:139&#x2013;148. 10.1038/s41586-023-06651-y 10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Love S, Perry A, Ironside J, Budka H (2018) Greenfield&#x2019;s neuropathology&#x2014;two volume set. CRC Press, Boca Raton</Citation></Reference><Reference><Citation>Matschke J, Lutgehetmann M, Hagel C, Sperhake JP, Schroder AS, Edler C et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19:919&#x2013;929. 10.1016/S1474-4422(20)30308-2 10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P et al (2023) Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380:e072529. 10.1136/bmj-2022-072529 10.1136/bmj-2022-072529</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Morenas-Rodriguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suarez-Calvet M et al (2022) Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer&#x2019;s disease: a longitudinal observational study. Lancet Neurol 21:329&#x2013;341. 10.1016/S1474-4422(22)00027-8 10.1016/S1474-4422(22)00027-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00027-8</ArticleId><ArticleId IdType="pmc">PMC8926925</ArticleId><ArticleId IdType="pubmed">35305339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mossad O, Nent E, Woltemate S, Folschweiller S, Buescher JM, Schnepf D et al (2021) Microbiota-dependent increase in delta-valerobetaine alters neuronal function and is responsible for age-related cognitive decline. Nat Aging 1:1127&#x2013;1136. 10.1038/s43587-021-00141-4 10.1038/s43587-021-00141-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-021-00141-4</ArticleId><ArticleId IdType="pubmed">37117525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nockher WA, Wick M, Pfister HW (1999) Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis. J Neuroimmunol 101:161&#x2013;169. 10.1016/s0165-5728(99)00141-1 10.1016/s0165-5728(99)00141-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(99)00141-1</ArticleId><ArticleId IdType="pubmed">10580799</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK et al (2022) Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 23:210&#x2013;216. 10.1038/s41590-021-01113-x 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Radke J, Meinhardt J, Aschman T, Chua RL, Farztdinov V, Lukassen S et al (2024) Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19. Nat Neurosci. 10.1038/s41593-024-01573-y 10.1038/s41593-024-01573-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01573-y</ArticleId><ArticleId IdType="pubmed">38366144</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonberger K, Mitterer M, Glaser K, Stecher M, Hobitz S, Schain-Zota D et al (2023) LC-MS-based targeted metabolomics for FACS-purified rare cells. Anal Chem 95:4325&#x2013;4334. 10.1021/acs.analchem.2c04396 10.1021/acs.analchem.2c04396</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.2c04396</ArticleId><ArticleId IdType="pmc">PMC9996616</ArticleId><ArticleId IdType="pubmed">36812587</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Bruck W, Priller J, Stadelmann C, Lassmann H, Prinz M (2021) Analyzing microglial phenotypes across neuropathologies: a practical guide. Acta Neuropathol 142:923&#x2013;936. 10.1007/s00401-021-02370-8 10.1007/s00401-021-02370-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02370-8</ArticleId><ArticleId IdType="pmc">PMC8498770</ArticleId><ArticleId IdType="pubmed">34623511</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Mossad O, Sievert A, Peres AG, Ringel E, Baasch S et al (2023) Neonatal immune challenge poses a sex-specific risk for epigenetic microglial reprogramming and behavioral impairment. Nat Commun 14:2721. 10.1038/s41467-023-38373-0 10.1038/s41467-023-38373-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38373-0</ArticleId><ArticleId IdType="pmc">PMC10175500</ArticleId><ArticleId IdType="pubmed">37169749</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Salie H, Tanevski J, Killmer S, Lago MS, Schlaak AE et al (2021) Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity 54(1594&#x2013;1610):e1511. 10.1016/j.immuni.2021.06.00210.1016/j.immuni.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C- (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22:e102&#x2013;e107. 10.1016/S1473-3099(21)00703-9 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC et al (2021) Attributes and predictors of long COVID. Nat Med 27:626&#x2013;631. 10.1038/s41591-021-01292-y 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8:416&#x2013;427. 10.1016/S2215-0366(21)00084-5 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Skorniewska Z, Hampshire A, Chalmers JD, Ho LP, Horsley A et al (2023) Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat Med 29:2498&#x2013;2508. 10.1038/s41591-023-02525-y 10.1038/s41591-023-02525-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02525-y</ArticleId><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Windhager J, Zanotelli VRT, Schulz D, Meyer L, Daniel M, Bodenmiller B et al (2023) An end-to-end workflow for multiplexed image processing and analysis. Nat Protoc 18:3565&#x2013;3613. 10.1038/s41596-023-00881-0 10.1038/s41596-023-00881-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-023-00881-0</ArticleId><ArticleId IdType="pubmed">37816904</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP et al (2021) Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595:565&#x2013;571. 10.1038/s41586-021-03710-0 10.1038/s41586-021-03710-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J et al (2024) Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 10.1038/s41590-023-01724-6 10.1038/s41590-023-01724-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J et al (2023) Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med 29:226&#x2013;235. 10.1038/s41591-022-02116-3 10.1038/s41591-022-02116-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>